TMP269,
1314890-29-3,
N-((4-(4-Phenylthiazol-2-yl)tetrahydro-2H-pyran-4-yl)methyl)-3-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)benzamide,
TMP-269,
TMP 269,
CHEMBL3110004,
N-{[4-(4-phenyl-1,3-thiazol-2-yl)oxan-4-yl]methyl}-3-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide,
C25H21F3N4O3S,
N-{[4-(4-Phenyl-1,3-Thiazol-2-Yl)tetrahydro-2h-Pyran-4-Yl]methyl}-3-[5-(Trifluoromethyl)-1,2,4-Oxadiazol-3-Yl]benzamide,
TMFO1,
compound 1 [PMID: 23524983],
BenzaMide, N-[[tetrahydro-4-(4-phenyl-2-thiazolyl)-2H-pyran-4-yl]Methyl]-3-[5-(trifluoroMethyl)-1,2,4-oxadiazol-3-yl]-,
GTPL7491,
SCHEMBL6976560,
AOB6266,
EX-A452,
HORXBWNTEDOVKN-UHFFFAOYSA-N,
HMS3653K12,
KUC113561N,
BCP09993,
2760AH,
BDBM50446481,
MFCD26522023,
s7324,
ZINC95828732,
AKOS025405229,
CS-2463,
SB19283,
NCGC00378626-06,
AK175546,
BC600541,
DA-46096,
HY-18360,
KSC-361-56-1,
FT-0700163,
SW219449-1,
A14128,
J-690126,
Z1982689601,
N-[[4-(4-phenylthiazol-2-yl)tetrahydropyran-4-yl]methyl]-3-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide,
N-[4-(4-Phenyl-2-thiazolyl)-tetrahydro-2H-pyran-4-ylmethyl]-3-[5-(trifluoromethyl)-1,2,4-oxadiazole-3-yl]benzamide,
NU9,
Pibrentasvir,
D0R7JA,
ACN-038069,